Series A co-led by Abingworth, DaVita Venture Group, and F-Prime with participation from Curie.Bio, SymBiosis, and U.S. Renal CarePartnership ...

Alongside R1 Therapeutics, Mestag Therapeutics and iDEL Therapeutics also brought in money on Tuesday, helping to push their ...

R1 Therapeutics is debuting with an oversubscribed $77.5 million series A financing aimed at advancing its first-in-class ...

A new study links bacterial viability to carbonate production in MICP, offering insights for the use of aged bacteria in ...

R1 plans to initiate a Phase IIb study of AP306 later this year.

A clinical-stage biotechnology company focused on developing therapies for kidney disease, with an initial emphasis on ...

Besides spring flowers and warmer weather, there's another reason to look forward to the days ahead - Amazon's Big Spring ...

Recycling bin filled with plastic bottles emphasizes waste management and environmental awareness. Image in public domain.

Plastic is one of the most durable materials humans have ever made. That durability has made it indispensable in medicine, ...

Researchers at the University of California, Irvine, have developed a polymeric biohybrid cardiac device that harnesses the ...

How risky scientists say BWX Technology’s (BWXT) proposed high-purity depleted uranium (HPDU) facility is to the surrounding ...

The chemical structure of this organic acid allows for high solubility and effective action in various water conditions. Frequently referred to in the industry as LABSA, this compound undergoes a ...